Mesto makrolidov v lechenii obostreniy khronicheskogo bronkhita
- Authors: Dvoretskiy L.I1
-
Affiliations:
- ММА им.И.М.Сеченова
- Issue: Vol 6, No 10 (2004)
- Pages: 774-780
- Section: Articles
- URL: https://ogarev-online.ru/2075-1753/article/view/91872
- ID: 91872
Cite item
Full Text
Abstract
Keywords
Full Text
##article.viewOnOriginalSite##References
- Mogukoc N.S, Karakurt B, Isaiska U et al. Acute purulent exacerbation of chronic obstructive pulmonary disease and Chlamydia pneumoniae infection. Am J Respir Crit Care 1999; 160: 349-53.
- Anzueto A, Norris S. Clarithromycin in 2003: sustained efficacy and safety in an era of rising antibiotic resistance. Intern J Antimicrob Agents. 2004; 24: 1-17.
- Blasi F, Damato S, Cosentini R et al. Chlamydia pneumoniae and chronic bronchitis: association with severity and bacterial clearance following treatment Thorax 2002; 57: 672-6.
- Козлов Р.С., Кречикова О.И., Сивая О.В. и др. Антимикробная резистентность S. pneumoniae в России: результаты проспективного многоцентрового исследования (фаза А проекта ПеГАС-1). Клин. микробиол. антимикроб. химиотер. 2002; 4б: 267-77.
- Zhanel G.G et al. J Antimicrob Chemother 2003; 52: 83-8.
- Davidson R.J. et al. Proccedings of the 13h European Congress of Clinical Microbiology and Infectious Disease. Glasgow 2003; Poster# P-103.
- Синопальников А.И., Гучев И.А. Макролиды: современная концепция применения. РМЖ 2003; 11(2).
- Miravitlles M. Exacerbations of chronic оbstructive pulmonary disease when are bacteria important? Eur Respir J 2002; 20(Suppl. 36):9-19.
- Beghi G, Berni F, Carratu L et al. Efficacy and tolerability of azithromycin versus amoxicillin/clavulanic acid in acute purulent exacerbation of chronic bronchitis. J Chemother 1995; 7: 146-52.
- Davies B.I, Maesen F.P.V, Gubbelmans R. Azithromycin in acute exacerbations of chronic bronchitis: an open clinical, microbiological and pharmacokinetic study. J Antimicrob Chemother 1989; 23: 743-51.
- De Abate C.A, Mathew C.P, Warmer J.H et al. The safety and efficacy of short cours (5-day) moxifloxacin versus asithromycin in the treatment of patients with acute exacerbacion of chronic bronchitis. Respir. Med 2000; 94: 1029-103.
- Kreis S.R, Herrera N, Golzar N, Fuller H.D et al. A comparison of moxifloxacin and azithromycin in the treatment of acute exacerbacions of chronic bronchitis. JCOM, 2000; 7(12): 33-7.
- Darkes M.J.M, Perry C.M. Сlarithromycin extended - release tablet: a review of its use in the managment of respiratory tract infections. Am J Respir Med 2003; 2: 175-201.
- Яковлев С.В., Ютанова Н.С. Клиническая эффективность кларитромицина в лекарственной форме с замедленным высвобождением (КЛАЦИД СР) при внебольничной пневмонии. Инфекции и антимикроб. тер. 2004.
- Guay D.R.P, Gustavson L.E, Devcich K.J et al. Pharmacokinetics and tolerability of extended - release clarithromycin. Clin.Ther. 2001; 23: 566-77.
- Martin S. The activity of 14-hydroxy clarithromycin, alone and in combination with clarithromycin, against penicillin - and erythromycin - resistant Streptococcus pneumoniae J Antimicrob Chemother 2001; 47: 581-7.
- Niederman (40) personal communication, 2003.
- Adler J.L, Jannetti W, Schneider D et al. Phase III, randomised, double - blind study of claritromycin extended - release and immediate - release formulations in the treatment of patients with acute exacerbation of chronic bronchitis. Clin Ther 2000; 22: 1410-20.
- Anzueto A, Fisher C.J, Busman T et al. Comparison of efficacy оf extended - release claritromycine tablets and amoxicillin/clavulanat tablets in the treatment of acute exacerbation of chronic bronchitis. Clin Ther 2001; 23: 72-86.
- Weiss K, Vanjaka A. An open - label, randomized, multicenter, comparative study of the efficacy and safety of 7 days of treatment with clarithromycin extended - release tablets versus clarithromycin immediate - release for the treatment of patients with acute bacterial exacerbation of chronic bronchitis.Canadian Clarithromycin Study Group on Bronchitis. Clin Ther 2002; 24: 2105-22.
- Nalepa P, Dobriniewska M, Busman T et al. Short - course therapy of acute bacterial exacerbation of chronic bronchitis: a double - blind, randomized, multicenter comparison of extended - release versus immediate - release clarithromycin. Curr.Med.Res.Opin. 2003; 19: 411-20.
- Adam D et al. Comparative efficacy of clarithromycin modified - release and clarithromycine immediate - release formulations in the treatment of LRTI. Clin Ther 2001; 23: 585-95.
- Devich K, Busman T, Olson C et al. Adverse events severity comparison with extended - release clarithromycin and immediate - release clarithromycin. Infection Disease Socirty of America: Chicago, 2002; poster 212.
- Guay D.R.P, Gustavson L.E, Devcich K.J et al. Pharmacokinetics and tolerability of extended - release clarithromycin. Clin Ther 2001; 23: 566-77.
- Tamaoki J. The effects of macrolides on inflammatory cells. Chest 2004; 125: 41-51.
- Gotfried M. Macrolides for the treatment of chronic sinusitis, asthma, and COPD. Chest 2004; 125: 52-61.
- Keicho N, .Kudoh S. Diffuse panbronchiolitis: Role of macrolides in therapy. Am J Resp Med 2002; 1/2: 119-31.
- Kurdowska A, Noble J.M, Griffith D.E. The effect of azythromycin and clarithromycin on ex vivo interleukin-8 (IL-8) release from whole blood and IL-8 production by human alveolar macrophages. J Antimicr Chemotherapy 2001; 47: 867-70.
- Mc Leod C.M, Hamid Q.A, Cameron L. et al. Anti - inflammatory activity of clarithromycin in adults with chronically inflamed sinus mucosa. Advances in therapy. 2001; 18: 75-82.
- Basyigit I, Yildiz F, Ozkara S.K et al. The effect of clarithromycin on inflammatory markers in chronic obstructive pulmonary disease: preliminary date Ann Pharmacother 2004 (in press).
- Pukhalsky A.L, Shmarina G.V, Kapranov N.I et al. Anti - inflammatiry and immunomodulating effects of clarithromycin in patients with cystic fibrosis lung disease. Mediators Inflamm. 2004; 13: 111-7.
- Mc Leod C et al. Mucolitical effect of clarithromycin once - a - day in chronic bronchitis. 3rd European congress of Chemotherapy (ECC) 2000, Madrid, Abstract T242.
- Tagaya E, Tamaokj J, Kondo M et al. Effect of short course of clarithromycin therapy on sputum production in patients with chronic airway hypersecretion. Chest, 2002; 122:213-8.
Supplementary files
